Sufficient blood, safe blood: can we have both?

[1]  M. Vermeulen,et al.  Hepatitis B virus transmission by blood transfusion during 4 years of individual‐donation nucleic acid testing in South Africa: estimated and observed window period risk , 2012, Transfusion.

[2]  C. Nübling,et al.  Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets , 2012, Transfusion.

[3]  E. Seifried,et al.  Safety and frequency of whole blood donations from elderly donors , 2012, Vox sanguinis.

[4]  J. Desenclos,et al.  Deferral from donating blood of men who have sex with men: impact on the risk of HIV transmission by transfusion in France , 2012, Vox sanguinis.

[5]  H. Ullum,et al.  International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 , 2012, Vox sanguinis.

[6]  D. Litaker,et al.  A spatial regression analysis of German community characteristics associated with voluntary non‐remunerated blood donor rates , 2012, Vox sanguinis.

[7]  E Seifried,et al.  How much blood is needed? , 2011, Vox sanguinis.

[8]  T. Gutteberg,et al.  Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam. , 2010, The Southeast Asian journal of tropical medicine and public health.

[9]  C. Prowse,et al.  A report on transmissible spongiform encephalopathies and transfusion safety , 2009, Vox sanguinis.

[10]  P. Gallian,et al.  Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti‐HCV, anti‐HIV, and p24/anti‐HIV combination assays in seroconversion panels , 2009, Transfusion.

[11]  Michael P Busch,et al.  Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus , 2008, Transfusion.

[12]  J. Echevarría,et al.  Acute hepatitis B virus window‐period blood donations detected by individual‐donation nucleic acid testing: a report on the first two cases found and interdicted in Spain , 2006, Transfusion.

[13]  E. Seifried,et al.  Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting , 1999, The Lancet.

[14]  P. Holland,et al.  The clinical significance of hepatitis B virus antigens and antibodies. , 1975, The Medical clinics of North America.

[15]  P. C. Das,et al.  Detection of hepatitis B surface antigen among Scottish blood donors: evaluation of sensitive tanned-cell haemagglutination-inhibition test. , 1975, British medical journal.

[16]  B. Moore,et al.  Hepatitis B antigenemia among blood donors: the changing scene. , 1975, Canadian Medical Association journal.

[17]  E. Seifried,et al.  NAT and viral safety in blood transfusion. , 2000, Vox sanguinis.

[18]  I. Husstedt.  HIV und Aids , 1998 .

[19]  U. Diekamp,et al.  [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994]. , 1996, Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine.

[20]  J. Catania,et al.  Prevalence and Social Distribution of Men Who Have Sex with Men: United States and Its Urban Centers , 1995 .